Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMDP) Net Margin (2016 - 2025)

Historic Net Margin for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to 7.62%.

  • LifeMD's Net Margin rose 25900.0% to 7.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.54%, marking a year-over-year increase of 74900.0%. This contributed to the annual value of 11.74% for FY2024, which is 38000.0% up from last year.
  • Per LifeMD's latest filing, its Net Margin stood at 7.62% for Q3 2025, which was up 25900.0% from 3.82% recorded in Q2 2025.
  • LifeMD's Net Margin's 5-year high stood at 1.5% during Q1 2025, with a 5-year trough of 75.43% in Q2 2021.
  • Over the past 5 years, LifeMD's median Net Margin value was 17.87% (recorded in 2023), while the average stood at 29.41%.
  • Examining YoY changes over the last 5 years, LifeMD's Net Margin showed a top increase of 1808900bps in 2021 and a maximum decrease of -382500bps in 2021.
  • Quarter analysis of 5 years shows LifeMD's Net Margin stood at 69.24% in 2021, then soared by 35bps to 45.21% in 2022, then surged by 78bps to 10.05% in 2023, then increased by 4bps to 9.61% in 2024, then increased by 21bps to 7.62% in 2025.
  • Its Net Margin stands at 7.62% for Q3 2025, versus 3.82% for Q2 2025 and 1.5% for Q1 2025.